PB 66 of 2015
National Health (Pharmaceutical benefits supplied by private hospitals) Amendment Determination 2015 (No. 1)
National Health Act 1953
I, JULIANNE QUAINE, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under subsection 99(4) of the National Health Act 1953.
Dated         29 June 2015
 
 
 
 
______________________________________
JULIANNE QUAINE
Assistant Secretary
Pharmaceutical Access Branch
Pharmaceutical Benefits Division
Department of Health
1       Name of Determination
         (1)   This Determination is the National Health (Pharmaceutical benefits supplied by private hospitals) Amendment Determination 2015 (No. 1).
         (2)   This Determination may also be cited as PB 66 of 2015.
2       Commencement
          This Determination commences on 1 July 2015.
3       Amendment of National Health (Pharmaceutical benefits supplied by private hospitals) Determination 2010
          Schedule 1 amends the National Health (Pharmaceutical benefits supplied by private hospitals) Determination 2010 made on 21 September 2010.
Schedule 1       Amendments
[1]     Section 6
                Omit the text after the heading ‘6  Rounding up and rounding down’
                substitute
  If the calculation of a price under this Determination includes a fraction of a cent, the final amount calculated is to then be rounded up or down to the nearest cent, with an amount of 0.5 of a cent or more being rounded up to the next cent.
[2]     Section 7
                Omit the text after the heading ‘7  Dangerous drug fee’
                substitute
If a pharmaceutical benefit is a dangerous drug, the Commonwealth must pay, in addition to any other amounts under this Determination, a dangerous drug fee where indicated in this Determination.
[3]     Subsection 8(1)
                omit
                substitute
(1)     If, under subsection 88 (6) of the Act and regulation 24 of the Regulations, a medical practitioner, instead of directing a repeated supply of a pharmaceutical benefit, directs the supply of a quantity or number of units of the benefit on 1 occasion, not exceeding the total quantity or number of units that could be prescribed if the medical practitioner directed a repeated supply, the price for the purpose of this Determination for the supply includes:
(a)           only 1 dispensing fee, that may be:
(i)         a ready-prepared dispensing fee; or
(ii)        an extemporaneously-prepared dispensing fee; and
(b)           the price, if any, of only 1 container; and
(c)           if a dangerous drug fee applies, only one such fee.
 
[4]     Section 11
                Omit the text after the heading ‘11  Dispensed price’
                substitute
(1)     The dispensed price for the supply of a ready-prepared pharmaceutical benefit by an approved hospital authority to a patient receiving treatment in or at a private hospital for which the authority is approved is:
(a)     if a quantity of the benefit that is ordered and supplied is equal to a multiple of a pack quantity of the benefit — the sum of:
(i)      for each pack quantity:
(A)    the approved ex-manufacturer price or the proportional ex-manufacturer price for the pack quantity; and
(B)    the storage and handling mark-up; and
(C)    the mark-up, worked out under section 12; and
(ii)     a ready-prepared dispensing fee; and
(iii)    if a dangerous drug fee applies, the dangerous drug fee; or
(b)    if a quantity of the benefit that is ordered and supplied is less than a pack quantity of the benefit — the sum of:
(i)      the amount worked out under section 14; and
(ii)     a ready-prepared dispensing fee; and
(iii)    if a dangerous drug fee applies, the dangerous drug fee; and
(iv)    an amount for the supply of a container, worked out under section 13; or
(c)    if a quantity of the benefit that is ordered and supplied is more than a multiple of a pack quantity of the benefit— the sum of:
(i)      for each pack quantity:
(A)    the approved ex-manufacturer price or the proportional ex-manufacturer price for the pack quantity; and
(B)    the storage and handling mark-up; and
(C)    the mark-up worked out under section 12; and
(ii)     for the remainder of the quantity that is less than a pack quantity— the amount worked out under section 14; and
(iii)    a ready-prepared dispensing fee; and
(iv)    if a dangerous drug fee applies, the dangerous drug fee.
(2)     However, for a ready-prepared pharmaceutical benefit that comprises the admixture of ready-prepared ingredients and is specified in Schedule 1 to the Determination under paragraph 98C (1) (b) of the National Health Act 1953:
(a)    the ready-prepared dispensing fee does not apply; and
(b)    an extemporaneously-prepared dispensing fee must be paid by the Commonwealth; and
(c)    no amount for the supply of the container is payable; and
(d)    if a dangerous drug fee applies, the dangerous drug fee.
[5]     Subsection 13(3)
                omit
                     1 May
                insert
                     15 June
[6]     Section 14, Step 1
                omit
                substitute
Step 1    Add together, for a pack quantity:
(a)    the approved ex-manufacturer price or the proportional ex-manufacturer price for the pack quantity; and
(b)    the storage and handling mark-up; and
(c)    the mark-up worked out under section 12; and
(d)   if a dangerous drug applies, the dangerous drug fee.